A. E. Dorofeyev

1.3k total citations · 1 hit paper
13 papers, 952 citations indexed

About

A. E. Dorofeyev is a scholar working on Surgery, Gastroenterology and Genetics. According to data from OpenAlex, A. E. Dorofeyev has authored 13 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Gastroenterology and 4 papers in Genetics. Recurrent topics in A. E. Dorofeyev's work include Gastrointestinal motility and disorders (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Inflammatory Bowel Disease (4 papers). A. E. Dorofeyev is often cited by papers focused on Gastrointestinal motility and disorders (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Inflammatory Bowel Disease (4 papers). A. E. Dorofeyev collaborates with scholars based in Ukraine, Romania and Russia. A. E. Dorofeyev's co-authors include Alexander Koliada, Lyudmila Sineok, Alexander Vaiserman, Oleh Lushchak, S.M. Tkach, Mariana Romanenko, Byong Duk Ye, Kang‐Moon Lee, Stefan Schreiber and Sigal Fishman and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

A. E. Dorofeyev

10 papers receiving 937 citations

Hit Papers

Association between body mass index and Firmicutes/Bacter... 2017 2026 2020 2023 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Dorofeyev Ukraine 4 573 354 160 146 137 13 952
Daniella DeCoffe Canada 7 519 0.9× 276 0.8× 103 0.6× 96 0.7× 121 0.9× 7 905
Douglas J. Kenny United States 5 734 1.3× 226 0.6× 117 0.7× 125 0.9× 145 1.1× 5 1.0k
Eelke Brandsma Netherlands 8 800 1.4× 403 1.1× 130 0.8× 98 0.7× 59 0.4× 13 1.1k
Bruno Sovran Netherlands 12 876 1.5× 344 1.0× 125 0.8× 90 0.6× 115 0.8× 16 1.2k
Erin R. Shanahan Australia 15 687 1.2× 364 1.0× 154 1.0× 66 0.5× 97 0.7× 38 1.2k
Renan Oliveira Corrêa Brazil 7 900 1.6× 290 0.8× 124 0.8× 191 1.3× 110 0.8× 10 1.3k
Kathleen Lee‐Sarwar United States 19 600 1.0× 528 1.5× 203 1.3× 114 0.8× 77 0.6× 40 1.4k
Kayla D. Battista United States 9 834 1.5× 281 0.8× 110 0.7× 126 0.9× 160 1.2× 11 1.2k
Aline Vieira Brazil 5 735 1.3× 238 0.7× 93 0.6× 155 1.1× 94 0.7× 6 1.1k
Sophia Levan United States 6 773 1.3× 361 1.0× 143 0.9× 129 0.9× 82 0.6× 12 1.2k

Countries citing papers authored by A. E. Dorofeyev

Since Specialization
Citations

This map shows the geographic impact of A. E. Dorofeyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Dorofeyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Dorofeyev more than expected).

Fields of papers citing papers by A. E. Dorofeyev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Dorofeyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Dorofeyev. The network helps show where A. E. Dorofeyev may publish in the future.

Co-authorship network of co-authors of A. E. Dorofeyev

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Dorofeyev. A scholar is included among the top collaborators of A. E. Dorofeyev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Dorofeyev. A. E. Dorofeyev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ткач, С. М., N. V. Kharchenko, & A. E. Dorofeyev. (2024). Antibiotic-associated microbiotoxicity and possible ways of its prevention. Review. 70–76. 1 indexed citations
2.
Ткач, С. М., et al.. (2024). Current concepts of chronic gastritis and gastropathies: new international consensus RE.GA.IN. SHILAP Revista de lepidopterología. 58(4). 286–294.
3.
Dorofeyev, A. E., et al.. (2023). Treatment options for patients with overlap of functional dyspepsia and irritable bowel syndrome. 32–38. 1 indexed citations
4.
Dorofeyev, A. E., et al.. (2022). Features of the mucous barrier in functional bowel diseases and ulcerative colitis. SHILAP Revista de lepidopterología. 56(2). 89–94.
7.
Dorofeyev, A. E., et al.. (2020). GENETIC POLYMORPHISM IN PATIENTS WITH EARLY AND LATE ONSET OF ULCERATIVE COLITIS. Wiadomości Lekarskie. 73(1). 87–90. 2 indexed citations
8.
Ye, Byong Duk, Olga Alexeeva, М. Ф. Осипенко, et al.. (2019). Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study. The Lancet. 393(10182). 1699–1707. 155 indexed citations
10.
Koliada, Alexander, A. E. Dorofeyev, Mariana Romanenko, et al.. (2017). Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiology. 17(1). 120–120. 760 indexed citations breakdown →
11.
Dorofeyev, A. E., et al.. (2017). Функціональна диспепсія. Різні механізми, комплексне лікування. SHILAP Revista de lepidopterología. 51(3). 209–212.
12.
Kim, Yong‐Hwan, Olga Alexeeva, М. Ф. Осипенко, et al.. (2017). DOP061 Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety results. Journal of Crohn s and Colitis. 11(suppl_1). S62–S62. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026